NIVALIS THERAPEUTICS INC - COM (NVLS)

CUSIP: 65481J109

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
9,970,764
Share change
-2,411,663
Total reported value
$22,334,000
Price per share
$2.24
Number of holders
38
Value change
-$20,212,829
Number of buys
15
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 65481J109?
CUSIP 65481J109 identifies NVLS - NIVALIS THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NIVALIS THERAPEUTICS INC - COM (NVLS) as of Q4 2016

As of 31 Dec 2016, NIVALIS THERAPEUTICS INC - COM (NVLS) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,970,764 shares. The largest 10 holders included DEERFIELD MANAGEMENT CO, BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, TIGER MANAGEMENT L.L.C., KINGDON CAPITAL MANAGEMENT, L.L.C., Rock Springs Capital Management LP, PANAGORA ASSET MANAGEMENT INC, VANGUARD GROUP INC, Anson Funds Management LP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 38 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.